Related Experiment Video
Updated: Jun 13, 2026
Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Eye-Tracking-Based Digital Therapeutic for ADHD in Children: Development and Preliminary Evaluation of an Adaptive
Seon-Chil Kim1, Sun-Young Lee2, Sang-Woo Lee3
1Department of Biomedical Engineering, School of Medicine, Keimyung University, 1095 Dalgubeol-daero, Daegu 42601, Republic of Korea.
Insights
Eye-tracking adaptive digital therapeutics show promise for improving attention in children with ADHD. This technology may enhance cognitive control and attentional performance in pediatric ADHD treatment.
Area of Science:
- Neuroscience
- Pediatric Psychology
- Digital Therapeutics
Background:
- Attention-Deficit/Hyperactivity Disorder (ADHD) presents significant challenges in childhood.
- Digital therapeutics offer novel treatment avenues for pediatric ADHD.
- Eye-tracking technology integration in digital tools is an emerging area.
Purpose of the Study:
- To evaluate the preliminary clinical effects of an eye-tracking-based adaptive learning guide.
- To assess the efficacy of a self-administered digital therapeutic for children with ADHD.
Main Methods:
- Prospective, randomized, parallel-group pilot trial.
- 40 children with ADHD (aged 6 to <12 years) participated.
- Comparison between eye-tracking adaptive digital therapeutics and conventional digital therapeutics over four weeks, alongside pharmacological treatment.
Main Results:
- Significant improvement in the Attention Composite score from Week 1 to Week 4.
- Attention-sensitive tasks demonstrated steeper improvement than standard tasks.
- Positive correlation between Attention Composite changes and CAT scores; significant group differences in Stroop and K-WISC-V Symbol Search.
Conclusions:
- Eye-tracking-based adaptive guidance may selectively enhance attentional performance and cognitive control in children with ADHD.
- Findings suggest potential for targeted cognitive improvement in pediatric ADHD.
- Larger-scale confirmatory studies are recommended to validate these preliminary results.
Background:
This study evaluated the preliminary clinical effects of an eye-tracking-based adaptive learning guide in a self-administered digital therapeutic for children with ADHD.
Methods:
In this prospective, randomized, parallel-group pilot trial, 40 children with ADHD (aged 6 to under 12 years) were allocated to an experimental group receiving eye-tracking-based adaptive digital therapeutic content or a control group receiving conventional digital therapeutic content, both combined with ongoing pharmacological treatment, for four weeks.
Results:
The Attention Composite significantly increased from 47.63 at Week 1 to 52.14 at Week 4, with attention-sensitive tasks showing steeper improvement trajectories than standard tasks. Changes in the Attention Composite were positively correlated with CAT score changes (r = 0.519, p = 0.0047). Significant between-group differences were observed in the Stroop Color-Word, Stroop Interference, and K-WISC-V Symbol Search measures, but not in the Word, Color, or Coding measures.
Conclusions:
These findings suggest that eye-tracking-based adaptive guidance may selectively improve attentional performance and cognitive control in children with ADHD, though larger-scale confirmatory studies are warranted.
